Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B vaccination in immunosuppressed anti-HBc-positive adults with low anti-HBs titers
2015-000557-21Phase 4Active
- Sponsor
- Vall d'Hebron University Hospital
- Start
- May 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of hepatitis B vaccine (recombinant) in hepatitis B (HBV) (2 arms), sponsored by Vall d'Hebron University Hospital. Primary endpoint: Development of anti-HBs titers greater than 100 mIU/mL after vaccination. Started May 2015; status: active.
02
Drugs
hepatitis B vaccine (recombinant)
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2015-000557-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000557-21.